Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study
Clinical and Experimental Nephrology · 2025
DOI: 10.1007/s10157-024-02552-0 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical and Experimental Nephrology, 2025. Verfasst von Toshiyuki Narimiya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Paraproteinemias, Kidney, Kidney Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science London, Chukyo Longevity Medical and Promotion Foundation.
Abstract (Originalsprache)
INTRODUCTION: Clinical epidemiological data on monoclonal gammopathy of renal significance (MGRS) are lacking. In this retrospective observational study, MGRS was compared with B-cell or plasma cell malignancies (BCM/PCM) with renal involvement to clarify differences in their clinical features. METHODS: Among the 1408 renal biopsies performed at our hospital, 25 MGRS and 18 BCM/PCM patients were identified. We investigated baseline characteristics and hematologic parameters of MGRS in reference to BCM/PCM using multivariable analysis. Cox proportional hazards analysis was performed for end-stage kidney disease (ESKD) and all-cause mortality. RESULTS: Comparing the MGRS with the BCM/PCM, mean differences in creatinine level, estimated glomerular filtration rate, and clonal bone marrow plasma cell percentage were - 2.76 mg/dL, 27.72 mL/min/1.73 m2, and - 18.86%, respectively (all P < 0.001). MGRS group had a predominance of glomerular lesions such as immunoglobulin-associated amyloidosis, cryoglobulinemic GN, and MIDD, and a lower risk of acute kidney injury/acute renal disease compared to BCM/PCM. During a median observation period of 23.7 months, clone-directed therapy was performed in 32.0% of patients in the MGRS group, compared to 83.3% of patients in the BCM/PCM group. Compared with BCM/PCM, MGRS had a hazard ratio of 0.66 (95% confidence interval (CI) 0.23-1.92, P = 0.45) for ESKD and 0.33 (95% CI 0.11-1.03, P = 0.06) for death in multivariate logistic regression analysis. CONCLUSIONS: The clinical characteristics of MGRS and BCM/PCM with monoclonal immunoglobulin-associated renal disease are disparate. Understanding these differences is crucial for developing tailored clinical approaches and therapeutic strategies to improve patient outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. hhayashi@fujita-hu.ac.jp.
- Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
- Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Förderung
- Japan Society for the Promotion of Science London
- Chukyo Longevity Medical and Promotion Foundation
Zitieren
APA
Narimiya, T., Hayashi, H., Ogata, S., Hara, S., Okamoto, A., Takahashi, K., Koide, S., Inaguma, D., Hasegawa, M., Tomita, A., Yuzawa, Y., & Tsuboi, N. (2025). Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02552-0
Vancouver
Narimiya T, Hayashi H, Ogata S, Hara S, Okamoto A, Takahashi K, et al. Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study. Clinical and Experimental Nephrology. 2025. doi:10.1007/s10157-024-02552-0
BibTeX
@article{Narimiya2025,
author = {Narimiya, Toshiyuki and Hayashi, Hiroki and Ogata, Soshiro and Hara, Shigeo and Okamoto, Akinao and Takahashi, Kazuo and Koide, Shigehisa and Inaguma, Daijo and Hasegawa, Midori and Tomita, Akihiro and Yuzawa, Yukio and Tsuboi, Naotake},
title = {Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study},
journal = {Clinical and Experimental Nephrology},
year = {2025},
doi = {10.1007/s10157-024-02552-0}
}
EUVIMED